Barry A. Osherow
voted to appoint Barry A. Osherow to fill the vacancy
Highest-materiality recent filing
Oxford Square Capital annual meeting: two directors elected, Ernst & Young ratified
Steven P. Novak elected with 18.2M for, 4.3M withheld; Charles M. Royce with 18.3M for, 4.2M withheld (33.5M broker non-votes each).
Oxford Square Capital Q2 2026 NAV $1.29, NII $5.1M, declares $0.035 monthly distributions
NAV per share fell to $1.29 from $1.32 at March 31, 2026; down from $1.69 at Dec 31, 2025.
Oxford Square Capital Q2 NAV $1.29, NII $5.1M, declares $0.035 monthly distributions
NAV per share $1.29 as of June 30, 2026, down from $1.32 on March 31, 2026.
Oxford Square Capital dismisses PwC, engages EY as independent auditor
Dismissed PwC as independent auditor and engaged EY effective May 26, 2026, approved by Board and audit committee.
Oxford Square Capital increases authorized shares from 100M to 300M via Articles of Amendment
Authorized shares of capital stock increased from 100M to 300M, all common stock, par value $0.01.
Entered into Amendment No. 1 to Amended and Restated Equity Distribution Agreement dated May 5, 2026.
Oxford Square Capital Q1 NAV drops to $1.32 from $1.69; net loss $25.5M
NAV per share fell to $1.32 at March 31, 2026, from $1.69 at Dec 31, 2025, a 22% decline.
Oxford Square NAV falls to $1.69; Q4 NII $5.4M; declares $0.035 monthly dividend
NAV per share at Dec 31, 2025 was $1.69, down 13.3% from $1.95 at Sep 30, 2025.
Oxford Square Q3 NAV drops to $1.95; declares $0.035/mo distributions; $25M buyback
NAV per share fell to $1.95 from $2.06 in Q2; net decrease in net assets from operations of $2.1M.
Oxford Square Capital elects director and ratifies auditor at annual meeting
Barry A. Osherow elected director with 15,651,247 for, 5,088,965 against, 25,443,974 broker non-votes.
Oxford Square Capital elects to redeem $24.8M of 6.25% Notes due 2026
Company will redeem all $24,790,750 outstanding principal of 6.25% Notes (CUSIP 69181V305; OXSQZ).
Oxford Square Q2 NII $5.5M ($0.08/shr); NAV falls to $2.06 from $2.09 QoQ
Total investment income $9.5M, down from $10.2M in Q1 2025 and $11.4M a year ago.
Oxford Square Capital issues $65M 7.75% Notes due 2030, ticker OXSQH
Issued $65M aggregate principal amount of 7.75% Notes due 2030; underwriters have option to purchase up to $9.75M additional.
Oxford Square Capital issues $65M of 7.75% Notes due 2030 in underwritten offering
Issuing $65.0M aggregate principal of 7.75% Notes due 2030, closing expected Aug 7, 2025.
Oxford Square Capital to redeem $10M of its 6.25% Notes due 2026 on July 18
Redeeming $10M of the $34.8M outstanding 6.25% Notes due 2026 (OXSQZ).
Oxford Square to redeem $10M of 6.25% Notes due 2026 on June 13
Partial redemption of $10M aggregate principal of $44.8M outstanding 6.25% Notes due 2026 (OXSQZ).
Oxford Square NAV falls to $2.09; net realized losses of $12.2M in Q1 2025
NAV per share $2.09 at Mar 31, 2025, down from $2.30 at Dec 31, 2024.
Oxford Square Q4 NAV $2.30, NII $0.09/share; maintains $0.035 monthly dividend
NAV per share of $2.30 at Dec 31, 2024, down from $2.35 at Sep 30, 2024.
Oxford Square Q3 NII $0.10/sh vs $0.13 Q2; NAV down to $2.35; distributions held at $0.105
NAV per share $2.35, down from $2.43 on June 30, 2024.
Oxford Square Capital Corp. annual meeting results: directors elected, auditor ratified
Jonathan H. Cohen elected director with 16,379,600 votes for, 1,671,641 withheld, 22,267,060 broker non-votes.
Oxford Square adds Lucid Capital Markets as sales agent under equity distribution agreement
Amended and Restated Equity Distribution Agreement dated August 16, 2024 adds Lucid Capital Markets as sales agent.
Oxford Square Q2 2024 NAV $2.43, NII $0.13/share; declares $0.035 monthly distributions
NAV per share $2.43 at June 30, 2024, up from $2.42 at March 31, 2024.
Oxford Square Capital Q1 NII $0.11/sh, NAV down to $2.42, net operating loss $1.8M
Net investment income $6.5M ($0.11/sh) vs $7.8M ($0.13/sh) in Q4 2023; total investment income $10.7M vs $12.3M.
Oxford Square Capital Q4 NAV falls to $2.55; declares $0.035 monthly dividends
NAV per share $2.55, down 8.3% from $2.78; net decrease in net assets $7.3M.
Oxford Square Capital redeems all $7.37M of 6.50% Notes due 2024 on Dec 21
Redemption of $7,370,225 aggregate principal amount of 6.50% Notes (OXSQL).
Oxford Square Q3 NAV falls to $2.78; NII $0.11/shr; monthly dividend cut to $0.035
NAV per share $2.78 at Sep 30, 2023, down from $2.88 at June 30, 2023.
Oxford Square Capital to redeem $7M of 6.50% Notes due 2024 on Nov 3, 2023
Company elects to redeem $7M of the $14.37M outstanding 6.50% Notes due 2024 (CUSIP 69181V206; NasdaqGS: OXSQL).
Oxford Square Capital shareholders elect Novak and Royce as directors, ratify PwC as auditor
Steven P. Novak elected with 13,819,734 votes for; 3,780,252 withheld; 20,458,846 broker non-votes.
Entered into Amendment No. 1 to Equity Distribution Agreement dated August 22, 2023.
Oxford Square Q2 2023 NAV $2.88, NII $0.13/share; declares $0.12 special dividend
NAV per share rose to $2.88 from $2.80 in Q1 2023; net increase in net assets of $11.6M from operations.
Oxford Square Capital Corp. to redeem $10M of 6.50% Notes due 2024 on Sept. 11
Company elected to redeem $10 million of the $24.37 million outstanding 6.50% Notes due 2024 (OXSQL).
Oxford Square Capital to redeem $40M of 6.50% Notes due 2024 on July 24, 2023
Elected to redeem $40M of $64.37M outstanding 6.50% Notes due 2024 (CUSIP 87244T307).
Oxford Square Capital raises $17.16M in rights offering, sells 6.45M shares at $2.66
Sold ~6.45M shares at $2.66 per share, gross proceeds $17.16M.
Oxford Square Capital launches rights offering for up to 16.6M common shares
Record holders on May 23 receive one right per three shares; each right buys one share at formula price (92.5% VWAP or 95% NAV).
Oxford Square Capital Q1 NII $0.13/share, NAV $2.80; declares $0.035 monthly distributions
Net investment income of $6.5M ($0.13 per share) flat vs prior quarter; total investment income rose to $12.9M from $11.9M.
Oxford Square Capital reports Q4 NAV of $2.78, down 17%; net operations loss $22.8M
Net asset value per share fell to $2.78 from $3.34 at Sept 30, 2022.
Oxford Square Capital Q3 NAV falls to $3.34; net operating loss of $11.1M on unrealized losses
NAV per share $3.34 at Sep 30, 2022, down from $3.67 in Q2 and $4.92 at Dec 2021.
Oxford Square Capital Corp. annual meeting results: Osherow elected director, PwC ratified
Stockholders elected Barry A. Osherow as director for term expiring 2025; 12,667,449 for, 2,140,571 withheld, 17,972,175 broker non-votes.
Oxford Square Q2 NAV drops 21% to $3.67; net decrease from operations of $43.4M
NAV per share fell to $3.67 from $4.65 in Q1; net assets decreased by $43.4M due to $46.2M unrealized losses.
Oxford Square Capital Q1 NAV falls to $4.65, net decrease $8.2M; declares $0.035/month dividend
NAV per share $4.65, down from $4.92 at Dec 31, 2021.
Oxford Square Capital Q4 NII $0.09/share; declares $0.035 monthly distribution
NAV per share $4.92 at Dec 31, 2021, down from $5.03 at Sep 30, 2021.
Oxford Square Q3 2021 NAV $5.03, net investment income $4.0M, declares $0.035 monthly distribution
NAV per share $5.03 as of Sept 30, 2021, up from $4.91 at June 30, 2021.
Shareholders reelect Jonathan H. Cohen (13,541,977 for, 1,108,943 withheld) to board.
Oxford Square Q2 2021 NII $0.06, NAV $4.91; declares $0.035/month distribution
Net investment income $2.8M ($0.06/share); down from $4.3M ($0.09) in Q2 2020.
Oxford Square Capital appoints Barry Osherow to board after Richard Neu resignation
Richard W. Neu resigned from the board effective July 12, 2021.
voted to appoint Barry A. Osherow to fill the vacancy
accepted the resignation of Richard W. Neu from his position as a member of the Board, effective immediately
Max materiality 0.85 · Median 0.55 · Most common event earnings